OLODATEROL\TIOTROPIUM: 4,430 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
4,430
Total FAERS Reports
342 (7.7%)
Deaths Reported
1,312
Hospitalizations
4,430
As Primary/Secondary Suspect
82
Life-Threatening
54
Disabilities
Active Ingredient: OLODATEROL HYDROCHLORIDE\TIOTROPIUM BROMIDE MONOHYDRATE ·
First Report: 19920101 · Latest Report: 20250918
What Are the Most Common OLODATEROL\TIOTROPIUM Side Effects?
#1 Most Reported
Dyspnoea
1,149 reports (25.9%)
#2 Most Reported
Wheezing
575 reports (13.0%)
#3 Most Reported
Asthma
526 reports (11.9%)
All OLODATEROL\TIOTROPIUM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 1,149 | 25.9% | 28 | 489 |
| Wheezing | 575 | 13.0% | 6 | 408 |
| Asthma | 526 | 11.9% | 7 | 402 |
| Cough | 485 | 11.0% | 4 | 217 |
| Drug ineffective | 403 | 9.1% | 7 | 172 |
| Chronic obstructive pulmonary disease | 373 | 8.4% | 32 | 245 |
| Therapeutic product effect incomplete | 319 | 7.2% | 0 | 238 |
| Loss of personal independence in daily activities | 307 | 6.9% | 6 | 225 |
| Pneumonia | 280 | 6.3% | 24 | 245 |
| Off label use | 265 | 6.0% | 15 | 91 |
| Sleep disorder due to a general medical condition | 259 | 5.9% | 6 | 197 |
| Bronchiectasis | 199 | 4.5% | 0 | 155 |
| Death | 186 | 4.2% | 186 | 18 |
| Chest discomfort | 175 | 4.0% | 0 | 117 |
| Asthma-chronic obstructive pulmonary disease overlap syndrome | 171 | 3.9% | 0 | 129 |
| Obstructive airways disorder | 167 | 3.8% | 0 | 118 |
| Product quality issue | 167 | 3.8% | 0 | 15 |
| Lung neoplasm malignant | 153 | 3.5% | 12 | 74 |
| Gastrooesophageal reflux disease | 146 | 3.3% | 0 | 88 |
| Oedema peripheral | 137 | 3.1% | 1 | 87 |
Who Reports OLODATEROL\TIOTROPIUM Side Effects? Age & Gender Data
Gender: 56.7% female, 43.3% male. Average age: 70.3 years. Most reports from: US. View detailed demographics →
Is OLODATEROL\TIOTROPIUM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2004 | 2 | 0 | 1 |
| 2007 | 1 | 0 | 0 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 4 | 2 | 1 |
| 2011 | 3 | 0 | 1 |
| 2012 | 5 | 0 | 2 |
| 2013 | 3 | 0 | 2 |
| 2014 | 7 | 1 | 1 |
| 2015 | 212 | 8 | 41 |
| 2016 | 414 | 50 | 139 |
| 2017 | 323 | 18 | 75 |
| 2018 | 286 | 21 | 66 |
| 2019 | 194 | 14 | 42 |
| 2020 | 249 | 29 | 71 |
| 2021 | 213 | 16 | 38 |
| 2022 | 184 | 19 | 36 |
| 2023 | 171 | 20 | 46 |
| 2024 | 101 | 8 | 24 |
| 2025 | 59 | 2 | 10 |
What Is OLODATEROL\TIOTROPIUM Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 2,048 |
| Chronic obstructive pulmonary disease | 1,881 |
| Asthma | 165 |
| Emphysema | 141 |
| Dyspnoea | 52 |
| Bronchitis chronic | 19 |
| Lung disorder | 19 |
| Bronchiectasis | 18 |
| Bronchitis | 10 |
| Lung neoplasm malignant | 9 |
OLODATEROL\TIOTROPIUM vs Alternatives: Which Is Safer?
OLODATEROL\TIOTROPIUM vs OLOPATADINE
OLODATEROL\TIOTROPIUM vs OLUTASIDENIB
OLODATEROL\TIOTROPIUM vs OMACETAXINE MEPESUCCINATE
OLODATEROL\TIOTROPIUM vs OMADACYCLINE
OLODATEROL\TIOTROPIUM vs OMALIZUMAB
OLODATEROL\TIOTROPIUM vs OMAVELOXOLONE
OLODATEROL\TIOTROPIUM vs OMBITASVIR
OLODATEROL\TIOTROPIUM vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OLODATEROL\TIOTROPIUM vs OMEGA-3-ACID ETHYL ESTERS
OLODATEROL\TIOTROPIUM vs OMEGA-3-CARBOXYLIC ACIDS
Official FDA Label for OLODATEROL\TIOTROPIUM
Official prescribing information from the FDA-approved drug label.